Lexaria Bioscience Corp.
New Filing
CIK: 0001348362·Biotechnology·NEVADA·Filed: Sep 18, 2026
Total Offering
$113,492
Amount Sold
$113,492
Investors
3
First Sale
Sep 9, 2026
Offering Details
- Type
- Option to Acquire
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Christopher Bunka | |
| John Docherty | |
| Richard Christopher | |
| Michael Shankman | |
| Nicholas Baxter | |
| William Edward McKechnie | |
| ALBERT REESE | |
| Bal Bhullar |
Company
SEC Filing
0001348362-26-000002
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free